Correction to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225-228. DOI: 10.1089/jop.2022.0160.

Abstract

Journal of Ocular Pharmacology and TherapeuticsVol. 39, No. 5 CorrectionOpen AccessCorrection to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225–228. DOI: 10.1089/jop.2022.0160is erratum ofDuration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque EyesPublished Online:12 Jun 2023https://doi.org/10.1089/jop.2022.0160.correxAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail In the april 2023 issue of Journal of Ocular Pharmacology and Therapeutics (vol. 39, no. 3; 225–228) a figure requires correction. In Figure 2 on page 227, there is an error in the scale of the x-axis. This error had no effect on the scientific content or conclusions. The changes made do not affect the conclusions drawn either in this experiment or in this study. The original Figure 2 image is shown below left, and the correct image below right. The figure legend in the original publication does not require correction.Original Figure 2:Updated Figure 2:The online version has been corrected to reflect this. The authors apologize for this error.FiguresReferencesRelatedDetailsRelated articlesDuration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes4 Apr 2023Journal of Ocular Pharmacology and Therapeutics Volume 39Issue 5Jun 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Correction to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225–228. DOI: 10.1089/jop.2022.0160.Journal of Ocular Pharmacology and Therapeutics.Jun 2023.359-359.http://doi.org/10.1089/jop.2022.0160.correxcreative commons licensePublished in Volume: 39 Issue 5: June 12, 2023PDF download